Skip to main content
Clinical Trials/NCT03842033
NCT03842033
Active, not recruiting
Not Applicable

Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients

Arkansas Children's Hospital Research Institute1 site in 1 country370 target enrollmentMarch 4, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric Asthma
Sponsor
Arkansas Children's Hospital Research Institute
Enrollment
370
Locations
1
Primary Endpoint
Change in Asthma Control Test (ACT) Score
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this research study is to test how good an app is in making asthma easier to manage for 372 adolescents/young adults. The app is a mobile version of the asthma action plan.

Detailed Description

The proposed project aligns with our prior work targeting high-risk pediatric asthma populations in non-inner city environments by targeting adolescents at risk for future exacerbations from the Patient-Centered Medical Home (PCMH) at Arkansas Children's Hospital (ACH). We propose to conduct a 3-arm randomized, controlled trial with 372 adolescents with uncontrolled asthma to test the effectiveness of mAAP. mAAP provides real-time, personalized feedback, asthma education, and data logging/tracking capabilities.

Registry
clinicaltrials.gov
Start Date
March 4, 2019
End Date
December 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age ≥12 and \<21 years
  • Persistent asthma according to national guidelines criteria
  • Asthma Control Test (ACT) score ≤19
  • Prescribed a preventive (controller) asthma medication in the past 6 months
  • Access to a smartphone compatible with the PEAKmAAP and NutriMap
  • Access to the internet
  • Able to read and speak English

Exclusion Criteria

  • Significant underlying respiratory disease other than asthma, such as cystic fibrosis
  • Significant co-morbid conditions, such as moderate to severe developmental delay that could interfere with the adolescent's ability to self-monitor asthma
  • Current smoker
  • Participation in the investigator's or other asthma clinical trials in the previous 6 months

Outcomes

Primary Outcomes

Change in Asthma Control Test (ACT) Score

Time Frame: 3 months

The primary outcome measure will be the change from ACT score ≤19 (uncontrolled asthma) to ACT \>19 (controlled asthma) at 3 months. ACT is a validated five question survey that computes a number indicating asthma control. The instrument range is 1-25, with 25 indication well controlled asthma. A score of less than or equal 19 is considered poorly controlled asthma.

Secondary Outcomes

  • Mediators of Asthma Control(12 months)
  • Healthcare Utilization(12 months)
  • Change in Asthma Control Test (ACT) Score to Access Secondary Outcomes(12 months)
  • Composite Asthma Severity Index (CASI) score(12 months)
  • Asthma Control Classification(12 months)
  • Lung Function and Airway Inflammation(12 months)

Study Sites (1)

Loading locations...

Similar Trials